Lumican inhibits cell migration through α2Β1 integrin

Experimental Cell Research

Volumn 316, Issue 17, 2010, Pages 2922-2931

  Zeltz, Cédric ^a   Brézillon, Stéphane ^a   Käpylä, Jarmo ^c   Eble, Johannes A ^d   Bobichon, Hélène ^a   Terryn, Christine ^a   Perreau, Corinne ^a   Franz, Clemens M ^e   Heino, Jyrki ^c   Maquart, François Xavier ^a,b   Wegrowski, Yanusz ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF TURKU   (Finland)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Cell migration; Lumican; SLRP; 2 1 integrin, I domain

Indexed keywords

LUMICAN; SMALL INTERFERING RNA; VERY LATE ACTIVATION ANTIGEN 2; ALPHA2 INTEGRIN; FOCAL ADHESION KINASE; KERATAN SULFATE; PROTEIN BINDING; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CHINESE HAMSTER; CHO CELL; CONTROLLED STUDY; FOCAL ADHESION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; MICROSCOPY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; VELOCITY; WILD TYPE; ANIMAL; CELL MOTION; CHO CELL LINE; CRICETULUS; DRUG EFFECTS; HAMSTER; MELANOMA; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

CRICETULUS GRISEUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CHO CELLS; CHONDROITIN SULFATE PROTEOGLYCANS; CRICETINAE; CRICETULUS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRIN ALPHA2; INTEGRIN ALPHA2BETA1; KERATAN SULFATE; MELANOMA; PHOSPHORYLATION; PROTEIN BINDING;

EID: 77956884942     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.002     Document Type: Article

References (44)

1. Corpuz L.M., Funderburgh J.L., Funderburgh M.L., Bottomley G.S., Prakash S., Conrad G.W. Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J. Biol. Chem. 1996, 271:9759-9763.
2. Dolhnikoff M., Morin J., Roughley P.J., Ludwig M.S. Expression of lumican in human lungs. Am. J. Respir. Cell. Mol. Biol. 1998, 19:582-587.
3. Grover J., Chen X.N., Korenberg J.R., Roughley P.J. The human lumican gene. Organization, chromosomal location and expression in articular cartilage. J. Biol. Chem. 1995, 270:21942-21949.
4. Schaefer L., Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J. Biol. Chem. 2008, 283:21305-21309.
5. Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., Lamantia C., Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 1998, 141:1277-1286.
6. Wu F., Vij N., Roberts L., Lopez-Briones S., Joyce S., Chakravarti S. A novel role of the lumican core protein in bacterial vlipopolysaccharide-induced innate immune response. J. Biol. Chem. 2007, 282:26409-26417.
7. Matsuda Y., Yamamoto T., Kudo M., Kawahara K., Kawamoto M., Nakajima Y., Koizumi K., Nakazawa N., Ishiwata T., Naito Z. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int. J. Oncol. 2008, 33:1177-1185.
8. Nikitovic D., Berdiaki A., Zafiropoulos A., Katonis P., Tsatsakis A., Karamanos N.K., Tzanakakis G.N. Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J. 2008, 275:350-361.
9. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 2003, 9:207-214.
10. Vuillermoz B., Khoruzhenko A., D'Onofrio M.F., Ramont L., Venteo L., Perreau C., Antonicelli F., Maquart F.X., Wegrowski Y. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 2004, 296:294-306.
11. Brézillon S., Venteo L., Ramont L., D'Onofrio M.F., Perreau C., Pluot M., Maquart F.X., Wegrowski Y. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin. Exp. Dermatol. 2007, 32:405-416.
12. Brézillon S., Radwanska A., Zeltz C., Malkowski A., Ploton D., Bobichon H., Perreau C., Malicka-Blaszkiewicz M., Maquart F.X., Wegrowski Y. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett. 2009, 283:92-100.
13. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2009, 10:445-457.
14. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369.
15. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007, 39:86-93.
16. Kuphal S., Bauer R., Bosserhoff A.K. Integrin signaling in malignant melanoma. Cancer Metastasis Rev. 2005, 24:195-222.
17. Parise L.V., Lee J., Juliano R.L. New aspects of integrin signaling in cancer. Semin. Cancer Biol. 2000, 10:407-414.
18. Tsuji T., Kawada Y., Kai-Murozono M., Komatsu S., Han S.A., Takeuchi K., Mizushima H., Miyazaki K., Irimura T. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin. Exp. Metastasis 2002, 19:127-134.
19. Kim J.K., Xu Y., Xu X., Keene D.R., Gurusiddappa S., Lang X., Wary K.K., Hook M. A novel binding site in collagen type III for integrins alpha1beta1 and alpha2beta1. J. Biol. Chem. 2005, 280:32512-32520.
20. Funderburgh J.L., Mitschler R.R., Funderburgh M.L., Roth M.R., Chapes S.K., Conrad G.W. Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest. Ophthalmol. Vis. Sci. 1997, 38:1159-1167.
21. D'Onofrio M.F., Brézillon S., Baranek T., Perreau C., Roughley P.J., Maquart F.X., Wegrowski Y. Identification of beta-1 integrin as mediator of melanoma cell adhesion to lumican. Biochem. Biophys. Res. Commun. 2008, 365:266-272.
22. Guidetti G., Bertoni A., Viola M., Tira E., Balduini C., Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 2002, 100:1707-1714.
23. Zeltz C., Brézillon S., Perreau C., Ramont L., Maquart F.X., Wegrowski Y. Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration. FEBS Lett. 2009, 583:3027-3032.
24. Brézillon S., Zeltz C., Schneider L., Terryn C., Vuillermoz B., Ramont L., Perreau C., Pluot M., Diebold M.D., Radwanska A., Malicka-blaszkiewicz M., Maquart F.X., Wegrowski Y. Lumican inhibits B16F1 melanoma cell lung metastasis. J. Physiol. Pharmacol. 2009, 60(suppl4):415-422.
25. Zahm J.M., Kaplan H., Hérard A.L., Doriot F., Pierrot D., Somelette P., Puchelle E. Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil. Cytoskeleton 1997, 37:33-43.
26. Ivaska J., Käpylä J., Pentikäinen O., Hoffren A.M., Hermonen J., Huttunen P., Johnson M.S., Heino J. A peptide inhibiting the collagen binding function of integrin α2I domain. J. Biol. Chem. 1999, 274:3513-3521.
27. Tulla M., Pentikäinen O.T., Viitasalo T., Käpylä J., Impola U., Nykvist P., Nissinen L., Johnson M.S., Heino J. Selective binding of collagen subtypes by integrin α1I, α2I, and α10I domains. J. Biol. Chem. 2001, 276:48206-48212.
28. Käpylä J., Jäälinoja J., Tulla M., Ylöstalo J., Nissinen L., Viitasalo T., Vehviläinen P., Marjomäki V., Nykvist P., Säämänen A.M., Farndale R.W., Birk D.E., Ala-Kokko L., Heino J. The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix. J. Biol. Chem. 2004, 279:51677-51687.
29. Aquilina A., Korda M., Bergelson J.M., Humphries M.J., Farndale R.W., Tuckwell D. A Novel gain-of-function mutation of the integrin α2 VWFA domain. Eur. J. Biochem. 2002, 269:1136-1144.
30. Tulla M., Lahti M., Puranen J.S., Brandt A.M., Käpylä J., Domogatskaya A., Salminen T.A., Tryggvason K., Johnson M.S., Heino J. Effects of conformational activation of integrin alpha 1I and alpha 2I domains on selective recognition of laminin and collagen subtypes. Exp. Cell Res. 2008, 314:1734-1743.
31. Eble J.A., Beermann B., Hinz H.J., Schmidt-Hederich A. Alpha2beta1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J. Biol. Chem. 2001, 276:12274-12284.
32. Nykvist P., Tu H., Ivaska J., Käpylä J., Pihlajaniemi T., Heino J. Distinct recognition of collagen subtypes by alpha(1)beta(1) and alpha(2)beta(1) integrins. Alpha(1)beta(1) mediates cell adhesion to type XIII collagen. J. Biol. Chem. 2000, 275:8255-8261.
33. Taubenberger A., Cisneros D.A., Friedrichs J., Puech P.H., Muller D.J., Franz C.M. Revealing early steps of alpha2beta1 integrin-mediated adhesion to collagen type I by using single-cell force spectroscopy. Mol. Biol. Cell 2007, 18:1634-1644.
34. Krensel K., Lichtner R.B. Selective increase of alpha2-integrin sub-unit expression on human carcinoma cells upon EGF-receptor activation. Int. J. Cancer 1999, 80:546-552.
35. Petrie R.J., Doyle A.D., Yamada K.M. Random versus directionally persistent cell migration. Nat. Rev. Mol. Cell Biol. 2009, 10:538-549.
36. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin alpha2beta1. Cell 2000, 101:47-56.
37. Moretti S., Martini L., Berti E., Pinzi C., Giannotti B. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res. 1993, 3:235-239.
38. Ziober B.L., Chen Y.Q., Ramos D.M., Waleh N., Kramer R.H. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ. 1999, 10:479-490.
39. Lee S., Bowrin K., Hamad A.R., Chakravarti S. Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J. Biol. Chem. 2009, 284:23662-23669.
40. Radwanska A., Baczynska D., Nowak D., Brézillon S., Popow A., Maquart F.X., Wegrowski Y., Malicka-Blaszkiewicz M. Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci. 2008, 83:651-660.
41. Käpylä J., Ivaska J., Riikonen R., Nykvist P., Pentikäinen O., Johnson M., Heino J. Integrin alpha(2)I domain recognizes type I and type IV collagens by different mechanisms. J. Biol. Chem. 2000, 275:3348-3354.
42. Woodall B.P., Nyström A., Iozzo R.A., Eble J.A., Niland S., Krieg T., Eckes B., Pozzi A., Iozzo R.V. Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity. J. Biol. Chem. 2008, 283:2335-2343.
43. Fiedler L.R., Schönherr E., Waddington R., Niland S., Seidler D.G., Aeschlimann D., Eble J.A. Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J. Biol. Chem. 2008, 283:17406-17415.
44. Knight C.G., Morton L.F., Onley D.J., Peachey A.R., Messen A.J., Smethurst P.A., Tuckwell D.S., Farndale R.W., Barnes M.J. Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J. Biol. Chem. 1998, 273:33287-33294.